Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (241-250 of 290) with videos related to

Pageof 29
Sort By:
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trialsCapucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
Nature Communications|June 20, 2018
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomasShai Rosenberg, Iva Simeonova, Franck Bielle, et al.
The Journal of Clinical Investigation|June 28, 2021
SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphiaLuiz H Geraldo, Yunling Xu, Laurent Jacob, et al.
Nature Communications|June 13, 2015
TCF12 is mutated in anaplastic oligodendrogliomaKarim Labreche, Iva Simeonova, Aurélie Kamoun, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterationsMarie Morfouace, Franck Bielle, Evangelia Razis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2019
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 StudyKaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, et al.
Neuro-Oncology|May 19, 2019
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network studyKarim Labreche, Mailys Daniau, Amit Sud, et al.
Clinical and Translational Medicine|July 9, 2022
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastomaMaïté Verreault, Irma Segoviano Vilchis, Shai Rosenberg, et al.
JCO Precision Oncology|June 1, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With GliomaPatrick R Benusiglio, Fikret Elder, Mehdi Touat, et al.
Pageof 29

Showing results (241-250 of 290) with videos related to

Sort By:
Pageof 29
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trialsCapucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
Nature Communications|June 20, 2018
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomasShai Rosenberg, Iva Simeonova, Franck Bielle, et al.
The Journal of Clinical Investigation|June 28, 2021
SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphiaLuiz H Geraldo, Yunling Xu, Laurent Jacob, et al.
Nature Communications|June 13, 2015
TCF12 is mutated in anaplastic oligodendrogliomaKarim Labreche, Iva Simeonova, Aurélie Kamoun, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterationsMarie Morfouace, Franck Bielle, Evangelia Razis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2019
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 StudyKaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, et al.
Neuro-Oncology|May 19, 2019
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network studyKarim Labreche, Mailys Daniau, Amit Sud, et al.
Clinical and Translational Medicine|July 9, 2022
Identification of growth hormone receptor as a relevant target for precision medicine in low-EGFR expressing glioblastomaMaïté Verreault, Irma Segoviano Vilchis, Shai Rosenberg, et al.
JCO Precision Oncology|June 1, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With GliomaPatrick R Benusiglio, Fikret Elder, Mehdi Touat, et al.
Pageof 29